The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2S,3S,Z)-N'-benzylidene-2-(1,3-dioxoisoindolin-2-yl)-3-methylpentanehydrazide ID: ALA3580856
PubChem CID: 122178479
Max Phase: Preclinical
Molecular Formula: C21H21N3O3
Molecular Weight: 363.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC[C@H](C)[C@@H](C(=O)N/N=C\c1ccccc1)N1C(=O)c2ccccc2C1=O
Standard InChI: InChI=1S/C21H21N3O3/c1-3-14(2)18(19(25)23-22-13-15-9-5-4-6-10-15)24-20(26)16-11-7-8-12-17(16)21(24)27/h4-14,18H,3H2,1-2H3,(H,23,25)/b22-13-/t14-,18-/m0/s1
Standard InChI Key: YXGPRAKCMVWTTC-AHXWOFLFSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0825 2.3453 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0907 -2.3426 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8208 1.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2072 2.3788 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8520 -1.2531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3215 1.3677 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0552 2.6770 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5559 2.6972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3246 1.4082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8245 1.4262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5901 0.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8558 -1.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3559 -1.1898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5903 0.1001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1168 -2.5616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7283 -3.5941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0519 -1.2394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 1 0
8 10 1 0
9 11 2 0
7 12 2 0
10 13 1 6
13 14 2 0
10 15 1 0
13 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
15 25 1 0
25 26 1 0
15 27 1 1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.42Molecular Weight (Monoisotopic): 363.1583AlogP: 2.85#Rotatable Bonds: 6Polar Surface Area: 78.84Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.61CX Basic pKa: 1.73CX LogP: 3.63CX LogD: 3.63Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.49Np Likeness Score: -0.99
References 1. Coelho LCD, Cardoso MVdO, Moreira DRM, Gomes PATdM, Cavalcanti SMT, Oliveira AR, Filho GBdO, Siqueira LRPd, Barbosa MdO, Borba EFdO, Silva TGd, Kaskow B, Karimi M, Abraham LJ, Leite ACL. (2014) Novel phthalimide derivatives with TNF- and IL-1 expression inhibitory and apoptotic inducing properties, 5 (6): [10.1039/C4MD00070F ]